Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

3,710.00p
   
  • Change Today:
    -40.00p
  • 52 Week High: 5,060.00
  • 52 Week Low: 3,225.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 1,809
  • Market Cap: £193.65m

Regulatory News

Notice of AGM 08-Nov-2024 07:57 RNS
Director/PDMR Shareholding 31-Oct-2024 07:00 RNS
Results for the year ended 30 June 2024 28-Oct-2024 07:00 RNS
Holding(s) in Company 25-Oct-2024 10:37 RNS
Holding(s) in Company 16-Oct-2024 13:51 RNS
Director/PDMR Shareholding 30-Apr-2024 07:00 RNS
Holding(s) in Company 12-Apr-2024 11:05 RNS
Interim Results 25-Mar-2024 07:00 RNS
Director/PDMR Shareholding 29-Jan-2024 15:15 RNS
Result of AGM 07-Dec-2023 15:26 RNS
Director/PDMR Shareholding 28-Nov-2023 15:26 RNS
Holding(s) in Company 16-Nov-2023 12:40 RNS
Posting of Annual Report and Notice of AGM 10-Nov-2023 16:23 RNS
Holding(s) in Company 07-Nov-2023 12:07 RNS
Holding(s) in Company 01-Nov-2023 16:07 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 3,710.00p
Change Today -40.00p
% Change -1.07 %
52 Week High 5,060.00
52 Week Low 3,225.00
Volume 1,809
Shares Issued 5.22m
Market Cap £193.65m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
67.17% below the market average67.17% below the market average67.17% below the market average67.17% below the market average67.17% below the market average
40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average
Price Trend
14.7% below the market average14.7% below the market average14.7% below the market average14.7% below the market average14.7% below the market average
46.94% above the sector average46.94% above the sector average46.94% above the sector average46.94% above the sector average46.94% above the sector average
Income
2.30% above the market average2.30% above the market average2.30% above the market average2.30% above the market average2.30% above the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Growth
43.01% below the market average43.01% below the market average43.01% below the market average43.01% below the market average43.01% below the market average
17.65% below the sector average17.65% below the sector average17.65% below the sector average17.65% below the sector average17.65% below the sector average

Bioventix Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 07-Nov-24 11-Apr-24
Paid 21-Nov-24 26-Apr-24
Amount 87.00p 68.00p

Trades for 21-Nov-2024

Time Volume / Share Price
16:24 0 @ 3,700.00p
16:24 1 @ 3,700.00p
15:46 12 @ 3,794.00p
15:23 24 @ 3,746.00p
15:01 144 @ 3,794.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page